Eszopiclone
Links shared publicly online about this topic
Treating Insomnia and Depression -- The Evidence for Eszopiclone | Psychiatry
touchpsychiatry.com — “Title: Treating Insomnia and Depression -- The Evidence for Eszopicloneshort title: Treating Insomnia and DepressionShort summary: Insomnia, a widespread condition that affects individuals of all ages and genders, is” View full resource at touchpsychiatry.com
Most Recently Shared on February 23, 2011 at 2:02 pm By:
Touch Psychiatry Medical Journal and Psychology
Treating Insomnia and Depression – The Evidence for Eszopiclone http://bit.ly/fd57zI
Rheumatology Article | Mucositis
mdlinx.com — “Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies” View full resource at mdlinx.com
Most Recently Shared on December 31, 2010 at 8:56 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hemat... http://bit.ly/eBCHjs #Rheumatology
Family Medicine Article | Sleep Initiation and Maintenance Disorders
mdlinx.com — “Eszopiclone in the Management of Insomnia Among Elderly Patients” View full resource at mdlinx.com
Most Recently Shared on June 1, 2011 at 6:09 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Eszopiclone in the Management of Insomnia Among Elderly Patients: Clinical Medicine: Geriatrics http://bit.ly/jtlEDv #FamPractice
Neurology Article | Sleep Initiation and Maintenance Disorders
mdlinx.com — “Eszopiclone in the Management of Insomnia Among Elderly Patients” View full resource at mdlinx.com
Most Recently Shared on May 25, 2011 at 5:36 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Eszopiclone in the Management of Insomnia Among Elderly Patients: Clinical Medicine: Geriatrics http://bit.ly/lEbDgS #neuro
Neurology Medical News about Parkinson Disease
mdlinx.com — “Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placebo” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 11:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placebo: Mov... http://bit.ly/dnj53T #neurology #mdlinx
SLEEP - Article Abstract
journalsleep.org — “On-line web source for articles published in SLEEP, the official journal of the Associated Professional Sleep Societies, LLC, A joint venture of the American Academy of Sleep Medicine and the Sleep Research Society.” View full resource at journalsleep.org
Most Recently Shared on February 1, 2010 at 2:52 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Eszopiclone (Lunesta) effective and well tolerated in clinical trial for insomnia in elderly population. http://ow.ly/12yZo
YouTube - Lunesta's Channel
youtube.com — “Lunesta® (eszopiclone) is a prescription sleep aid that helps the majority of people get back to sleeping the way they want to.* Wondering if LUNESTA may be right for you? Talk to you healthcare professional to learn how LUNESTA works. For more information, visit http://www.lunesta.com. *In clinical studies LUNESTA was proven effective to help the majority of patients fall asleep quickly and stay asleep for up to 7 hours.” View full resource at youtube.com
Most Recently Shared on December 19, 2010 at 4:31 pm By:
eyeonfda Pharma and Health Lawyer
I subscribed to Lunesta's channel on YouTube. http://www.youtube.com/user/Lunesta?feature=autoshare
Lupin settles litigation over Lunesta tablets; stock up - The Economic Times
economictimes.indiatimes.com — “Pharma major Lupin and its subsidiary Lupin Pharmaceuticals Inc have settled ongoing litigation with Sunovion Pharmaceuticals over Lunesta (Eszopiclone) tablets.” View full resource at economictimes.indiatimes.com
Most Recently Shared on January 3, 2011 at 2:06 pm By:
Economic Times: Lupin settles litigation over Lunesta tablets; stock up. http://bit.ly/fWjRXn
Two-Week Course of Sleep Aid Increases CPAP Adherence in OSA Patients at Six Months
newswise.com — “New research suggests that patients newly diagnosed with obstructive sleep apnea (OSA) who use a short-course of the sleep aid, eszopiclone, when beginning continuous positive airway pressure (CPAP) therapy, are more adherent with therapy in six months.” View full resource at newswise.com
Most Recently Shared on May 17, 2009 at 6:46 pm By:
Two-Week Course of Sleep Aid Increases CPAP Adherence in OSA Patients at Six Months http://bit.ly/98FRc
Sleeping pills linked to higher risk of cancer, death, study says - South Florida Sun-Sentinel.com
sun-sentinel.com — “A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem ( Ambien ), temazepam (Restoril), eszopiclone ( Lunesta ) and zaleplon (Sonata) are more likely to develop cancer , and far more likely to die prematurely, than those who take no sleep aids.” View full resource at sun-sentinel.com
Most Recently Shared on March 24, 2012 at 8:14 am By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Sleeping pills linked to higher risk of cancer, death, study says - Sun Sentinel http://t.co/hWPCZteP #health
Sleeping pills linked to higher risk of cancer, death, study says - OrlandoSentinel.com
orlandosentinel.com — “A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem ( Ambien ), temazepam (Restoril), eszopiclone ( Lunesta ) and zaleplon (Sonata) are more likely to develop cancer , and far more likely to die prematurely, than those who take no sleep aids.” View full resource at orlandosentinel.com
Most Recently Shared on March 22, 2012 at 11:53 am By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Sleeping pills linked to higher risk of cancer, death, study says - Orlando Sentinel http://t.co/kJ2fgSvG #health
Sepracor's LUNESTA receives patent term extension from USPTO
news-medical.net — “Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.” View full resource at news-medical.net
Most Recently Shared on December 18, 2009 at 7:08 am By:
Sepracor's LUNESTA receives patent term extension from USPTO: Sepracor Inc. today announced that the United States ... http://bit.ly/5ZKwxb
Sleeping pills linked to higher risk of cancer, death, study says - latimes.com
latimes.com — “A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem ( Ambien ), temazepam (Restoril), eszopiclone ( Lunesta ) and zaleplon (Sonata) are more likely to develop cancer , and far more likely to die prematurely, than those who take no sleep aids.” View full resource at latimes.com
Most Recently Shared on February 29, 2012 at 5:23 pm By:
Darren Phelan Doctor, Emergency Physician, and Physician
No cause and effect, but compelling findings about sleep aids. http://t.co/UPTuuFZ2
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Touch Psychiatry
Touch Psychiatry is a medical journal aimed at professionals in the industry. Covering ways to fight depression, anxiety, bipolar conditions and many others.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
